Collection
Purinergic Signalling – Perspectives from Australia and New Zealand
- Submission status
- Closed
This issue aims to provide examples of purinergic research undertaken in Australia and New Zealand, spanning a range of purinergic molecules and pathways in different physiological and pathophysiological areas.
Reviews, original research articles, short communications and journal club articles will be considered for publication. All submissions must conform to the Submission Guidelines and be submitted via the manuscript submission portal. Subscription and open access options are available to authors. Enquiries can be sent to Ronald Sluyter (rsluyter@uow.edu.au).
Editors
-
Ronald Sluyter
Ronald Sluyter is a professor in the School of Chemistry and Molecular Bioscience, University of Wollongong and group leader in the Illawarra Health and Medical Research Institute. His group largely explores the roles of P2X7 in health and disease. He is Co-President of the Australian and New Zealand Purine Club.
-
Jennie Cederholm
Jennie Cederholm is a Senior Lecturer in the School of Medical Sciences (SoMS), UNSW Sydney. She is a member of the Sensori-Motor Physiology and Therapeutic Group in the Translational Neuroscience Facility, SoMS. Her research focuses on the molecular and cellular mechanisms of sensorineural hearing loss, in particular the role of P2X 2 receptors. She is Co-President of the Australian and New Zealand Purine Club.
-
Srdjan Vlajkovic
Associate Professor Srdjan Vlajkovic is a co-director of the Auditory and Vestibular Neuroscience Cluster in the Department of Physiology at the University of Auckland. His research focus is on molecular mechanisms of sensorineural hearing loss and the development of inner ear therapeutics. His research has contributed to the current understanding of the role of adenosine receptors in the repair of cochlear injury and restoration of hearing.
-
Carolina Gubert
The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia
-
Reece Sophocleous
University of Wollongong, Wollongong, Australia
Articles (12 in this collection)
-
-
The developmental journey of therapies targeting purine receptors: from basic science to clinical trials
Authors (first, second and last of 4)
- Seunga Han
- Haruna Suzuki-Kerr
- Peter R. Thorne
- Content type: Review Article
- Open Access
- Published: 29 September 2022
- Pages: 435 - 450
-
P2X7-mediated alteration of membrane fluidity is associated with the late stages of age-related macular degeneration
Authors (first, second and last of 11)
- Candace Drysdale
- Keunha Park
- Ben J. Gu
- Content type: Original Article
- Published: 24 August 2022
- Pages: 469 - 479
-
CD39 in the development and progression of pulmonary arterial hypertension
Authors (first, second and last of 4)
- Abbey Willcox
- Natasha Ting Lee
- Maithili Sashindranath
- Content type: Review Article
- Open Access
- Published: 10 August 2022
- Pages: 409 - 419
-
Adenosine receptor signalling in Alzheimer’s disease
Authors (first, second and last of 5)
- Phuc N. H. Trinh
- Jo-Anne Baltos
- Karen J. Gregory
- Content type: Review Article
- Open Access
- Published: 23 July 2022
- Pages: 359 - 381
-
The P2X1 receptor as a therapeutic target
Authors (first, second and last of 4)
- Felix M. Bennetts
- Jesse I. Mobbs
- David M. Thal
- Content type: Review Article
- Open Access
- Published: 11 July 2022
- Pages: 421 - 433
-
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons
Authors (first, second and last of 5)
- Rachael Bartlett
- Diane Ly
- Justin J. Yerbury
- Content type: Original Article
- Open Access
- Published: 28 April 2022
- Pages: 451 - 467
-
Burnstock oration — purinergic signalling in kidney transplantation
Authors
- Karen M. Dwyer
- Content type: Review Article
- Open Access
- Published: 26 April 2022
- Pages: 387 - 393
-
Chemical biology-based approaches to study adenosine A2A − dopamine D2 receptor heteromers
Authors
- Karen J. Gregory
- Manuela Jörg
- Content type: Journal Club
- Published: 29 March 2022
- Pages: 395 - 398
-
Inhibiting the P2Y13 receptor reduces IL-33 and HMGB1 lung concentrations and inflammatory cell infiltration in a murine model of asthma
Authors
- Lanxin Li
- Stephen J. Fuller
- Content type: Journal Club
- Published: 16 March 2022
- Pages: 403 - 405
-
Second meeting of the Australian and New Zealand Purine Club
Authors (first, second and last of 5)
- Carolina Gubert
- Reece A. Sophocleous
- Jennie M. E. Cederholm
- Content type: Meeting Report
- Published: 07 March 2022
- Pages: 385 - 386
-
The P2X7 receptor is a target of p53 and regulates haematopoiesis following radiation-induced genotoxic stress
Authors
- Peter Cuthbertson
- Ronald Sluyter
- Content type: Journal Club
- Published: 04 January 2022
- Pages: 399 - 401